101 related articles for article (PubMed ID: 6414326)
1. Bone marrow transplantation. III. Major problems and future directions.
Spruce WE
Am J Pediatr Hematol Oncol; 1983; 5(3):301-6. PubMed ID: 6414326
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression, graft-versus-host disease, and infection after bone marrow transplantation.
Kramer BS; Elfenbein GJ
J Fla Med Assoc; 1984 May; 71(5):321-8. PubMed ID: 6429272
[No Abstract] [Full Text] [Related]
3. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
Auletta JJ; Cooke KR
Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
[TBL] [Abstract][Full Text] [Related]
4. Review of vascularized bone marrow transplantation: current status and future clinical applications.
Gordon CR; Tai CY; Suzuki H; Strande LF; Ramsamooj R; Matthews MS; Black KS; Hewitt CW
Microsurgery; 2007; 27(4):348-53. PubMed ID: 17477415
[TBL] [Abstract][Full Text] [Related]
5. [Allogenic bone marrow transplantation complications. Part II].
Saloua L; Tarek BO; Abderrahman A; Abdeladhim BA
Tunis Med; 2000 Mar; 78(3):152-7. PubMed ID: 11026816
[TBL] [Abstract][Full Text] [Related]
6. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
Zöller M; Matzku S
Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
8. Is there an effective therapy for chronic graft-versus-host disease?
Schiller G; Gale RP
Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281
[No Abstract] [Full Text] [Related]
9. [Current status and future prospects of bone marrow transplantation].
Asano S
Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1250-5. PubMed ID: 2124250
[No Abstract] [Full Text] [Related]
10. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation.
Figuera A; Tomás JF; Otero MJ; Moreno E; García I; Fernández-Rañada JM
Am J Hematol; 1996 May; 52(1):68-9. PubMed ID: 8638625
[No Abstract] [Full Text] [Related]
12. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
13. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
14. Does oxypentifylline reduce the intensity of acute graft-versus-host disease following allogeneic bone marrow transplantation?
Ghosh K; Hutchinson RM
Haematologia (Budap); 1996; 28(1):45-51. PubMed ID: 9283904
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
Noga SJ; Hess AD
Semin Oncol; 1993 Oct; 20(5 Suppl 6):28-33. PubMed ID: 8211214
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic protocols for intestinal transplantation.
Pirenne J; Kawai M
Transpl Immunol; 2004; 13(2):131-7. PubMed ID: 15380543
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment.
Hiscott A; McLellan DS
Br J Biomed Sci; 2000; 57(2):163-9. PubMed ID: 10912294
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation in leukemia.
Gale RP
Ann Clin Res; 1981; 13(4-5):367-72. PubMed ID: 7039488
[TBL] [Abstract][Full Text] [Related]
19. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
